Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

23 Apr 2025 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with the receipt of USFDA approval for Dasatinib Tablets by Eugia Pharma Specialities, a wholly owned subsidiary of the Company.

The above information is a part of company’s filings submitted to BSE.